Siemens’ Companion Dx Deals Address Pharma’s Interest In Multiple Technologies

Separate deals with Viiv Healthcare and gene therapy specialist Tocagen illustrate the increasing emphasis on application of multiple technologies toward the development of companion diagnostics, as pharma strives to determine how best to assure market access to its targeted drugs.